Prediction of Cardiac Worsening Through to Cardiogenic Shock in Patients with Acute Heart Failure
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14792 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Benedikt N Beer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Heart Failure, Shock, Cardiogenic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Acute heart failure (AHF) can result in worsening of heart failure (WHF), cardiogenic shock (CS), or death. Risk factors for these adverse outcomes are not well characterized. This study aimed to identify predictors for WHF or new-onset CS in patients hospitalized for AHF. Methods and results Prospective cohort study enrolling consecutive patients with AHF admitted to a large tertiary care centre with follow-up until death or discharge. WHF was defined by the RELAX-AHF-2 criteria. CS was defined as SCAI stages B–E. Potential predictors were assessed by fitting logistic regression models adjusted for age and sex. N = 233 patients were enrolled, median age was 78 years, and 80 were women (35.9%). Ischaemic cardiomyopathy was present in 82 patients (40.8%). Overall, 96 (44.2%) developed WHF and 18 (9.7%) CS. In-hospital death (8/223, 3.6%) was related to both events (WHF: OR 6.64, 95% CI 1.21–36.55, P = 0.03; CS: OR 38.27, 95% CI 6.32–231.81, P < 0.001). Chronic kidney disease (OR 2.20, 95% CI 1.25–3.93, P = 0.007), logarithmized serum creatinine (OR 2.90, 95% CI 1.51–5.82, P = 0.002), cystatin c (OR 1.86, 95% CI 1.27–2.77, P = 0.002), tricuspid valve regurgitation (OR 2.08, 95% CI 1.11–3.94, P = 0.023) and logarithmized pro-adrenomedullin (OR 3.01, 95% CI 1.75–5.38, P < 0.001) were significant predictors of WHF. Chronic kidney disease (OR 3.17, 95% CI 1.16–9.58, P = 0.03), cystatin c (OR 1.88, 95% CI 1.00–3.53, P = 0.045), logarithmized pro-adrenomedullin (OR 2.90, 95% CI 1.19–7.19, P = 0.019), and tricuspid valve regurgitation (OR 10.44, 95% CI 2.61–70.00, P = 0.003) were significantly with new-onset CS.
Conclusions
Half of patients admitted with AHF experience WHF or new-onset CS. Chronic kidney disease, tricuspid valve regurgitation, and elevated pro-adrenomedullin concentrations predict these events. They could potentially serve as early warning signs for further deterioration in AHF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.
- Center for Population Health Innovation (POINT), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
ORCID-Profile: Benedikt N Beer
Förderung
- Else Kröner-Fresenius-Stiftung
Zitieren
APA
Beer, B. N., Kellner, C., Sundermeyer, J., Besch, L., Dettling, A., Kirchhof, P., Blankenberg, S., Magnussen, C., & Schrage, B. (2024). Prediction of Cardiac Worsening Through to Cardiogenic Shock in Patients with Acute Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.14792
Vancouver
Beer BN, Kellner C, Sundermeyer J, Besch L, Dettling A, Kirchhof P, et al. Prediction of Cardiac Worsening Through to Cardiogenic Shock in Patients with Acute Heart Failure. ESC Heart Failure. 2024. doi:10.1002/ehf2.14792
BibTeX
@article{Beer2024,
author = {Beer, Benedikt N and Kellner, Caroline and Sundermeyer, Jonas and Besch, Lisa and Dettling, Angela and Kirchhof, Paulus and Blankenberg, Stefan and Magnussen, Christina and Schrage, Benedikt},
title = {Prediction of Cardiac Worsening Through to Cardiogenic Shock in Patients with Acute Heart Failure},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14792}
}
EUVIMED